Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats

Psychopharmacology

Volumn 170, Issue 1, 2003, Pages 80-88

  Watanabe, Takeshi ^a   Nakagawa, Takayuki ^a   Yamamoto, Rie ^a   Maeda, Akifumi ^a   Minami, Masabumi ^a   Satoh, Masamichi ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Central nucleus of amygdala; Conditioned place aversion; Morphine withdrawal; Noradrenaline adrenoceptor

Indexed keywords

ATENOLOL; BETA 2 ADRENERGIC RECEPTOR; BUTOXAMINE; MORPHINE; NALOXONE; NORADRENALIN; PROPRANOLOL;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MALE; MORPHINE ADDICTION; NEUROMODULATION; NONHUMAN; NORADRENERGIC SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; WITHDRAWAL SYNDROME;

ADRENERGIC BETA-ANTAGONISTS; AMYGDALA; ANIMALS; AVOIDANCE LEARNING; BUTOXAMINE; CONDITIONING, OPERANT; MALE; MORPHINE; NALOXONE; NARCOTIC ANTAGONISTS; NOREPINEPHRINE; PROPRANOLOL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA-1; RECEPTORS, ADRENERGIC, BETA-2; SUBSTANCE WITHDRAWAL SYNDROME; TIMOLOL;

EID: 0242407478     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00213-003-1504-0     Document Type: Article

References (59)

1. Aghajanian GK (1978) Tolerance of locus coeruleus neurones to morphine and suppression of withdrawal response by clonidine. Nature 276:186-188
2. Alheid GF, de Olmos JS, Beltramino CA (1995) Amygdala and extended amygdala. In: Paxinos G (ed.) The rat nervous system. Academic Press, New York, pp 495-578
3. Asan E (1998) The catecholaminergic innervation of the rat amygdala. Adv Anat Embryol Cell Biol 142:1-118
4. Bourgeais L, Gauriau C, Bernard J-F (2001) Projection from the nociceptive area of the central nucleus of the amygdala to the forebrain: a PHA-L study in the rat. Eur J Neurosci 14:229-255
5. Caille S, Espejo EF, Reneric JP, Cador M, Koob GF, Stinus L (1999) Total neurotoxic lesion of noradrenergic neurons of the locus coeruleus does not alter either naloxone-precipitated or spontaneous opiate withdrawal nor does it influence ability of clonidine to reverse opiate withdrawal. J Pharmacol Exp Ther 290:881-892
6. Calvino B, Lagowska J, Ben-Ari Y (1979) Morphine withdrawal syndrome: Differential participation of structures located within the amygdaloid complex and striatum of the rat. Brain Res 177:19-34
7. Campeau S, Davis M (1995) Involvement of the central nucleus and basolateral complex of the amygdala in fear conditioning measured with fear-potentiated startle in rats trained concurrently with auditory and visual conditioned stimuli. J Neurosci 15:2301-2311
8. Casada JH, Dafny N (1991) Restraint and stimulation of bed nucleus of the stria terminalis produce similar stress-like behaviors. Brain Res Bull 27:207-212
9. Chieng B, Christie MJ (1995) Lesions to terminals of noradrenergic locus coeruleus neurones do not inhibit opiate withdrawal behaviour in rats. Neurosci Lett 186:37-40
10. Clayton EC, Williams CL (2000) Adrenergic activation of the nucleus tractus solitarius potentiates amygdala norepinephrine release and enhances retention performance in emotionally arousing and spatial memory tasks. Behav Brain Res 112:151-158
11. Davis M, Shi C (1999) The extended amygdala: are the central nucleus of amygdala and the bed nucleus of the stria terminalis differentially involved in fear versus anxiety? Ann NY Acad Sci 877:281-291
12. Delfs JM, Zhu Y, Druhan JP, Aston-Jones G (2000) Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 403:430-434
13. Done C, Silverstone P, Sharp T (1992) Effect of naloxone-precipitated morphine withdrawal on noradrenaline release in rat hippocampus in vivo. Eur J Pharmacol 215:333-336
14. Everitt BJ, Parkinson JA, Olmstead MC, Arroyo M, Robeldo P, Robbins TW (1999) Associative processes in addiction and reward: The role of amygdala-ventral striatal subsystems. Ann NY Acad Sci 877:412-438
15. Fallon JH, Koziell DA, Moore RY (1978) Catecholamine innervation of the basal forebrain. II. Amygdala, suprarhinal and entorhinal cortex. J Comp Neurol 180:509-532
16. Feldman S, Weidenfeld J (1998) The excitatory effects of the amygdala on hypothalamo-pituitary-adrenocortical responses are mediated by hypothalamic norepinephrine, serotonin, and CRF-41. Brain Res Bull 45:389-393
17. Frenois F, Cador M, Caillé S, Stinus L, Moine CL (2002) Neural correlates of the motivational and somatic components of naloxone-precipitated morphine withdrawal. Eur J Neurosci 16:1377-1389
18. Gallagher M, Chiba AA (1996) The amygdala and emotion. Curr Opin Neurobiol 6:221-227
19. Gallagher M, Kapp BS, Musty RE, Driscoll PA (1977) Memory formation: evidence for a specific neurochemical system in the amygdala. Science 198:423-425
20. Gibson RD, Tingstad JE (1970) Formulation of a morphine implantation pellet suitable for tolerance-physical dependence studies in mice. J Pharm Sci 59:426-427
21. Gracy KN, Dankiewicz LA, Koob GF (2001) Opiate withdrawal-induced Fos immunoreactivity in the rat extended amygdala parallels the development of conditioned place aversion. Neuropsychopharmacology 24:152-160
22. Gray TS (1993) Amygdaloid CRF pathways: role in autonomic, neuroendocrine, and behavioral responses to stress. Ann NY Acad Sci 697:53-60
23. Gunne LM (1959) Noradrenaline and adrenaline in the rat brain during acute and chronic morphine administration and during withdrawal. Nature 184:1950-1951
24. Harris GC, Aston-Jones G (1993) Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal. Neuropsychopharmacology 9:303-311
25. Henke PG (1984) The bed nucleus of the stria terminalis and immobilization stress: unit activity, escape behaviour and gastric pathology in rats. Behav Brain Res 11:35-45
26. Honkaniemi J, Kainu T, Ceccatelli S, Rechardt L, Hokfelt T, Pelto-Huikko M (1992) Fos and jun in rat central amygdaloid nucleus and paraventricular nucleus after stress. Neuroreport 3:849-852
27. Kelsey JE, Arnold SR (1994) Lesion of the dorsomedial amygdala, but not the nucleus accumbens, reduce the aversiveness of morphine withdrawal in rats. Behav Neurosci 108:1119-1127
28. Khoshbouei H, Cecchi M, Dove S, Javors M, Morilak DA (2002) Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem Behav 71:407-417
29. Killcross S, Robbins TW, Everitt BJ (1997) Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature 388:377-380
30. Koob GF (1999) The role of the striatopallidal and extended amygdala systems in drug addiction. Ann NY Acad Sci 877:445-460
31. Koob GF, Wall TL, Bloom FE (1989) Nucleus accumbens as a substrate for the aversive stimulus effects of opiate withdrawal. Psychopharmacology 98:530-534
32. Koob GF, Maldonado R, Stinus L (1992) Neural substrates of opiate withdrawal. Trends Neurosci 15:186-191
33. Kosten TA (1994) Clonidine attenuates conditioned aversion produced by naloxone-precipitated opiate withdrawal. Eur J Pharmacol 254:59-63
34. Liang KC, Juler RG, McGaugh JL (1986) Modulating effects of posttraining epinephrine on memory: involvement of the amygdala noradrenergic system. Brain Res 368:125-133
35. Liang KC, Chen LL, Huang TE (1995) The role of amygdala norepinephrine in memory formation: involvement in the memory enhancing effect of peripheral epinephrine. Chin J Physiol 38:81-91
36. Llorens C, Martres MP, Bardry M, Schwartz JC (1978) Hypersensitivity to noradrenaline in cortex after chronic morphine: relevance to tolerance and dependence. Nature 274:603-605
37. Maldonado R (1997) Participation of noradrenergic pathway in the expression of opiate withdrawal: Biochemical and pharmacological evidence. Neurosci Biobehav Rev 21:91-104
38. Maldonado R, Stinus L, Gold LH, Koob GF (1992) Role of different brain structures in the expression of the physical morphine withdrawal syndrome. J Pharmacol Exp Ther 261:669-677
39. Moore RY, Bloom FE (1979) Central catecholamine neuron systems: anatomy and physiology of the norepinephrine and epinephrine systems. Annu Rev Neurosci 2:113-168
40. Mucha RP (1987) Is the motivational effect of opiate withdrawal reflected by common somatic indices of precipitated withdrawal? A place conditioning study in the rat. Brain Res 418:214-220
41. Nader K, van der Kooy D (1996) Clonidine antagonizes the aversive effects of opiate withdrawal and the rewarding effects of morphine only in opiate withdrawal rats. Behav Neurosci 110:389-400
42. Pacak K, Palkovits M, Kventnansky R, Fukuhara K, Armando I, Kopin IJ, Goldstein DS (1993) Effects of single or repeated immobilization on release of norepinephrine and its metabolites in the central nucleus of the amygdala in conscious rats. Neuroendocrinology 57:626-633
43. Paxinos G, Watson C (1998) The rat brain in stereotaxic coordinates, 4th edn. Academic Press, San Diego
44. Petrov T, Krukoff TL, Jhamandas JH (1993) Branching projections of catecholaminergic brainstem neurons to the paraventricular hypothalamic nucleus and the central nucleus of the amygdala in the rat. Brain Res 609:81-92
45. Radulovic J, Kammermeier J, Spiess J (1998) Relationship between Fos production and classical fear conditioning: Effects of novelty, latent inhibition, and unconditioned stimulus preexposure. J Neurosci 18:7452-7461
46. Rasmussen K, Beitner DB, Krystal JH, Aghajanian GK, Nestler EJ (1990) Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological and biochemical correlates. J Neurosci 10:2308-2317
47. Rossetti ZL, Longu G, Mercuro G, Gessa GL (1993) Extraneuronal noradrenaline in the prefrontal cortex of morphine-dependent rats: tolerance and withdrawal mechanisms. Brain Res 609:316-320
48. Schaefer GJ, Michael RP (1986) Changes in response rates and reinforcement thresholds for intracranial self-stimulation during morphine withdrawal. Pharmacol Biochem Behav 25:1263-1269
49. Stinus L, LeMoal M, Koob GF (1990) Nucleus accumbens and amygdala are possible substrates for the aversive stimulus effects of opiate withdrawal. Neuroscience 37:767-773
50. Tanaka M, Yoshida M, Emoto H, Ishi H (2000) Noradrenaline systems in the hypothalamus, amygdala and locus coeruleus are involved in the provocation of anxiety; basic studies. Eur J Pharmacol 405:397-406
51. Tanaka T, Yokoo H, Mizoguchi K, Yoshida M, Tsuda A, Tanaka M (1991) Noradrenaline release in the rat amygdala is increased by stress: studies with intracerebral microdialysis. Brain Res 544:174-176
52. Taylor JR, Elsworth JD, Garcia EJ, Grant SJ, Roth RH, Redmond DE Jr (1988) Clonidine infusions into the locus coeruleus attenuate behavioral and neurotoxic changes associated with naloxone-precipitated withdrawal. Psychopharmacology 96:121-134
53. Tseng LF, Loh HH, Wei ET (1975) Effects of clonidine on morphine withdrawal signs in the rat. Eur J Pharmacol 30:93-99
54. Tzschentke TM (1998) Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Progr Neurobiol 56:613-672
55. 2-receptors. Naunyn-Schiedeberg's Arch Pharmacol 329:293-298
56. Watanabe T, Nakagawa T, Yamamoto R, Maeda A, Minami M, Satoh M (2002a) Involvement of glutamate receptors within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats. Jpn J Pharmacol 88:399-406
57. Watanabe T, Yamamoto R, Maeda A, Nakagawa T, Minami M, Satoh M (2002b) Effects of excitotoxic lesions of the central or basolateral nucleus of the amygdala on naloxone-precipitated withdrawal-induced conditioned place aversion in morphine-dependent rats. Brain Res 958:423-428
58. Williams CL, Men D, Clayton EC, Gold PE (1998) Norepinephrine release in the amygdala after systemic injection of epinephrine or escapable footshock: contribution of the nucleus of the solitary tract. Behav Neurosci 112:1414-1422
59. Zardetto-Smith AM, Gray TS (1990) Organization of peptidergic and catecholaminergic efferents from the nucleus of the solitary tract to the rat amygdala. Brain Res Bull 25:875-887